STOCK CAPITAL (Tables)
|
3 Months Ended |
Mar. 31, 2019 |
Share-based Payment Arrangement [Abstract] |
|
Schedule of Composition of Common Stock Capital |
|
|
Number of shares
|
|
|
|
Authorized
|
|
|
Issued and outstanding
|
|
|
|
March 31, 2019
|
|
|
December 31, 2018
|
|
|
March 31, 2019
|
|
|
December 31, 2018
|
|
|
|
(unaudited)
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
Stock of $0.0001 par value:
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
125,000,000
|
|
|
|
125,000,000
|
|
|
|
47,501,363
|
|
|
|
46,052,802 |
|
Schedule of Stock Option Activity |
A summary of the activity in the share options granted to employees and members of the board of directors for the three months ended March 31, 2019 (unaudited) and related information follows:
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
average
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
remaining
|
|
|
|
|
|
|
Number
|
|
|
average
|
|
|
contractual
|
|
|
Aggregate
|
|
|
|
of
|
|
|
exercise
|
|
|
term
|
|
|
intrinsic
|
|
|
|
Options
|
|
|
price
|
|
|
in years
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2018
|
|
|
2,401,893
|
|
|
|
11.04
|
|
|
|
6.19
|
|
|
|
58,323
|
|
Granted
|
|
|
267,852
|
|
|
|
36.15
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(25,512
|
)
|
|
|
11.33
|
|
|
|
|
|
|
|
|
|
Forfeited or expired
|
|
|
(10,625
|
)
|
|
|
14.51
|
|
|
|
|
|
|
|
|
|
Outstanding as of March 31, 2019
|
|
|
2,633,608
|
|
|
|
13.58
|
|
|
|
6.33
|
|
|
|
63,544
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as of March 31, 2019
|
|
|
2,592,033
|
|
|
|
13.44
|
|
|
|
6.30
|
|
|
|
62,901
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable as of March 31, 2019
|
|
|
1,896,037
|
|
|
|
8.32
|
|
|
|
5.46
|
|
|
|
55,675 |
|
Schedule of RSU Activity |
A summary of the activity in the RSUs (excluding PSUs) granted to employees and members of the board of directors for the three months ended March 31, 2019 (unaudited) is as follows:
|
|
Number of
RSUs
|
|
|
Weighted average
grant date
fair value
|
|
Unvested as of December 31, 2018
|
|
|
2,807,232
|
|
|
|
34.40
|
|
Granted
|
|
|
306,562
|
|
|
|
38.55
|
|
Vested
|
|
|
(223,210
|
)
|
|
|
31.14
|
|
Forfeited
|
|
|
(96,018
|
)
|
|
|
33.91
|
|
Unvested as of March 31, 2019
|
|
|
2,794,566
|
|
|
|
35.13
|
|
|
Schedule of Options and RSUs Granted to Non-Employee Consultants |
The Company has granted options and RSUs to purchase common shares to non-employee consultants as of March 31, 2019 (unaudited) as follows:
|
|
Outstanding
|
|
|
|
|
|
Exercisable
|
|
|
|
|
as of
|
|
|
|
|
|
as of
|
|
|
Issuance
|
|
March 31,
|
|
|
Exercise
|
|
|
March 31,
|
|
Options exercisable
|
Date
|
|
2019
|
|
|
price
|
|
|
2019
|
|
through
|
|
|
|
|
|
|
|
|
|
|
|
2014
|
|
|
6,023
|
|
|
$3.51 - $5.01
|
|
|
|
5,245
|
|
October 29, 2024
|
2015
|
|
|
2,127
|
|
|
$0.00
|
|
|
|
-
|
|
|
2016
|
|
|
5,001
|
|
|
$0.00 - $15.34
|
|
|
|
-
|
|
September 21, 2026
|
2017
|
|
|
13,126
|
|
|
$0.00 - $13.70
|
|
|
|
-
|
|
March 15, 2027
|
2018
|
|
|
19,496
|
|
|
$0.00
|
|
|
|
-
|
|
|
2019
|
|
|
9,499
|
|
|
$0.00
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55,272
|
|
|
|
|
|
|
5,245
|
|
|
|
Schedule of Recognized Stock-Based Compensation Expense |
The Company recognized stock-based compensation expenses related to stock options, RSUs and PSUs granted to employees and non-employee consultants and ESPP in the condensed consolidated statement of income for the three months ended March 31, 2019 (unaudited) and 2018 (unaudited), as follows:
|
|
Three months ended March 31,
|
|
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
$
|
1,354
|
|
|
$
|
924
|
|
Research and development
|
|
|
3,490
|
|
|
|
2,382
|
|
Selling and marketing
|
|
|
2,404
|
|
|
|
2,204
|
|
General and administrative
|
|
|
2,456
|
|
|
|
1,339
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense
|
|
$
|
9,704
|
|
|
$
|
6,849
|
|